brain-cancer

Documents about brain-cancer

• Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases#909124ClinicalTrials.gov
• Keto-Brain:Investigating the Use of Ketogenic Diets in Brain Metastases#842587ClinicalTrials.gov
• Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors#981994ClinicalTrials.gov
• Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy#806851ClinicalTrials.gov
• Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)#918924ClinicalTrials.gov
• Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer#390929ClinicalTrials.gov
• The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factors#274201HAL (France)
• Validity of Brain Metastasis Risk Predictive Model in Hormone Positive Breast Cancer Patients#894380ClinicalTrials.gov
• Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma#899853ClinicalTrials.gov
• Whole Brain Radiation Using IMRT for Patients With Brain Metastases#872474ClinicalTrials.gov
• Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis#801264ClinicalTrials.gov
• A Trial for Treatment of Cancer Patients With Multiple Brain Metastases Undergoing Whole-Brain Radiotherapy#847957ClinicalTrials.gov
• Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention#834706ClinicalTrials.gov
• Measuring the Feasibility and Effect of a Virtual Reality Cognitive Training Intervention for Brain Cancer Survivors.#889607ClinicalTrials.gov
• SRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung Cancer#18604ClinicalTrials.gov
• Brain FGF2 and NCAM1 contribute to FGFR1-dependent progression of ER+ breast cancer brain metastases in young and aged hosts#238027bioRxiv / medRxiv
• Efficacy of metfOrmin in PrevenTIng Glucocorticoid-induced Diabetes in Patients With Brain Metastases#283217ClinicalTrials.gov
• Cell competition overcomes host tissue resistance to unleash tumor growth in a Drosophila brain cancer model#624939HAL (France)
• Sunitinib to Treat Recurrent Brain Cancer#800292ClinicalTrials.gov
• Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer#848563ClinicalTrials.gov
• Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma#873122ClinicalTrials.gov
• Feasibility and Clinically Application of Magnetic Resonance Fingerprinting#890343ClinicalTrials.gov
• Light Sedation or Intubated General Anesthesia in Patients With Brain Cancer Undergoing Craniotomy#890393ClinicalTrials.gov
• Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer#910290ClinicalTrials.gov
• T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery#900893ClinicalTrials.gov
• Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases#633735ClinicalTrials.gov
• Sacituzumab Tirumotecan（Sac-TMT） and Brain Radotherapy for EGFR+ NSCLC With Brain Mets#875961ClinicalTrials.gov
• BIRN (Biomedical Informatics Research Network) Resources Facilitate the Personalization of Malignant Brain Tumor#913637ClinicalTrials.gov
• High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood#980860ClinicalTrials.gov
• Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients.#1010046ClinicalTrials.gov
• Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme#174874ClinicalTrials.gov
• Promotion of Well-being of Young Adult Brain Cancer Survivors#863712ClinicalTrials.gov
• Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases#804177ClinicalTrials.gov
• The brain in the beam path – outcomes and biomarkers in clinical radiotherapy#922808GUPEA
• The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study#891211ClinicalTrials.gov
• Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis#623513ClinicalTrials.gov
• Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain Metastases#874723ClinicalTrials.gov
• HKI-272 for HER2-Positive Breast Cancer and Brain Metastases#913519ClinicalTrials.gov
• Improving Brain Function After Breast Cancer Study#898176ClinicalTrials.gov
• Pre- Versus Post-operative SRS for Resectable Brain Metastases#993580ClinicalTrials.gov
• Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases#854395ClinicalTrials.gov
• A Window of Opportunity Study of Patritumab Deruxtecan in Patients With Brain Metastases#980390ClinicalTrials.gov
• MRI Study of Changes in Blood-Brain/Tumor-Barrier Permeability in Patients With Brain Metastases During and After Radiotherapy#832650ClinicalTrials.gov
• Comparison of PET and Proton MRS Imaging to Evaluate Pediatric Brain Tumor Activity#880761ClinicalTrials.gov
• The Role of Blood-Brain Barrier in Brain Cancer: From Pathophysiology to Therapeutic Approaches.#15023NCBI PubMed Central
• Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma#300253ClinicalTrials.gov
• Genomic Study in Non-small Cell Lung Cancer Brain Metastasis#876625ClinicalTrials.gov
• Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study#1008282ClinicalTrials.gov
• Proteome-based Immunotherapy of Lung Cancer Brain Metastases#160154ClinicalTrials.gov
• Visualization of the Effect of Acupuncture on Brain Serotonin in Breast Cancer Survivors#854229ClinicalTrials.gov